These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 22849332

  • 41. Mutagenesis of beta-tubulin cysteine residues in Saccharomyces cerevisiae: mutation of cysteine 354 results in cold-stable microtubules.
    Gupta ML, Bode CJ, Dougherty CA, Marquez RT, Himes RH.
    Cell Motil Cytoskeleton; 2001 Jun; 49(2):67-77. PubMed ID: 11443737
    [Abstract] [Full Text] [Related]

  • 42. Binding modes of cabazitaxel with the different human β-tubulin isotypes: DFT and MD studies.
    Zhu L, Zhang C, Lü X, Song C, Wang C, Zhang M, Xie Y, Schaefer HF.
    J Mol Model; 2020 May 30; 26(6):162. PubMed ID: 32474655
    [Abstract] [Full Text] [Related]

  • 43. Structure-function relationships in yeast tubulins.
    Richards KL, Anders KR, Nogales E, Schwartz K, Downing KH, Botstein D.
    Mol Biol Cell; 2000 May 30; 11(5):1887-903. PubMed ID: 10793159
    [Abstract] [Full Text] [Related]

  • 44. Detection of human betaV-tubulin expression in epithelial cancer cell lines by tubulin proteomics.
    Verdier-Pinard P, Shahabi S, Wang F, Burd B, Xiao H, Goldberg GL, Orr GA, Horwitz SB.
    Biochemistry; 2005 Dec 06; 44(48):15858-70. PubMed ID: 16313188
    [Abstract] [Full Text] [Related]

  • 45. Elucidation of the anticancer potential and tubulin isotype-specific interactions of β-sitosterol.
    Pradhan M, Suri C, Choudhary S, Naik PK, Lopus M.
    J Biomol Struct Dyn; 2018 Jan 06; 36(1):195-208. PubMed ID: 27960611
    [Abstract] [Full Text] [Related]

  • 46. Exploring the interaction of Peloruside-A with drug resistant αβII and αβIII tubulin isotypes in human ovarian carcinoma using a molecular modeling approach.
    Kumbhar BV, Bhandare VV.
    J Biomol Struct Dyn; 2021 Apr 06; 39(6):1990-2002. PubMed ID: 32241247
    [Abstract] [Full Text] [Related]

  • 47. Modeling the yew tree tubulin and a comparison of its interaction with paclitaxel to human tubulin.
    Tuszynski JA, Craddock TJ, Mane JY, Barakat K, Tseng CY, Gajewski M, Winter P, Alisaraie L, Patterson J, Carpenter E, Wang W, Deyholos MK, Li L, Sun X, Zhang Y, Wong GK.
    Pharm Res; 2012 Nov 06; 29(11):3007-21. PubMed ID: 22833053
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. βI-tubulin mutations in the laulimalide/peloruside binding site mediate drug sensitivity by altering drug-tubulin interactions and microtubule stability.
    Kanakkanthara A, Rowe MR, Field JJ, Northcote PT, Teesdale-Spittle PH, Miller JH.
    Cancer Lett; 2015 Sep 01; 365(2):251-60. PubMed ID: 26052091
    [Abstract] [Full Text] [Related]

  • 50. Microtubules and resistance to tubulin-binding agents.
    Kavallaris M.
    Nat Rev Cancer; 2010 Mar 01; 10(3):194-204. PubMed ID: 20147901
    [Abstract] [Full Text] [Related]

  • 51. Regulation of β-tubulin isotypes by micro-RNA 100 in MCF7 breast cancer cells.
    Lobert S, Jefferson B, Morris K.
    Cytoskeleton (Hoboken); 2011 Jun 01; 68(6):355-62. PubMed ID: 21634028
    [Abstract] [Full Text] [Related]

  • 52. Paclitaxel-resistant cells have a mutation in the paclitaxel-binding region of beta-tubulin (Asp26Glu) and less stable microtubules.
    Hari M, Loganzo F, Annable T, Tan X, Musto S, Morilla DB, Nettles JH, Snyder JP, Greenberger LM.
    Mol Cancer Ther; 2006 Feb 01; 5(2):270-8. PubMed ID: 16505100
    [Abstract] [Full Text] [Related]

  • 53. Electrostatic contributions to colchicine binding within tubulin isotypes.
    Huzil JT, Barakat K, Tuszynski JA.
    Electromagn Biol Med; 2009 Feb 01; 28(4):355-64. PubMed ID: 20017626
    [Abstract] [Full Text] [Related]

  • 54. Structural insight into the mechanism of epothilone A bound to beta-tubulin and its mutants at Arg282Gln and Thr274Ile.
    Shi G, Wang Y, Jin Y, Chi S, Shi Q, Ge M, Wang S, Zhang X, Xu S.
    J Biomol Struct Dyn; 2012 Feb 01; 30(5):559-73. PubMed ID: 22731768
    [Abstract] [Full Text] [Related]

  • 55. Understanding the basis of drug resistance of the mutants of αβ-tubulin dimer via molecular dynamics simulations.
    Natarajan K, Senapati S.
    PLoS One; 2012 Feb 01; 7(8):e42351. PubMed ID: 22879949
    [Abstract] [Full Text] [Related]

  • 56. Combretastatin A-4 resistance in H460 human lung carcinoma demonstrates distinctive alterations in beta-tubulin isotype expression.
    Wehbe H, Kearney CM, Pinney KG.
    Anticancer Res; 2005 Feb 01; 25(6B):3865-70. PubMed ID: 16309172
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. Roles of beta-tubulin residues Ala428 and Thr429 in microtubule formation in vivo.
    Joe PA, Banerjee A, Ludueña RF.
    J Biol Chem; 2009 Feb 13; 284(7):4283-91. PubMed ID: 19074767
    [Abstract] [Full Text] [Related]

  • 59. Altered expression of M beta 2, the class II beta-tubulin isotype, in a murine J774.2 cell line with a high level of taxol resistance.
    Haber M, Burkhart CA, Regl DL, Madafiglio J, Norris MD, Horwitz SB.
    J Biol Chem; 1995 Dec 29; 270(52):31269-75. PubMed ID: 8537394
    [Abstract] [Full Text] [Related]

  • 60. Structure-based approaches for the design of benzimidazole-2-carbamate derivatives as tubulin polymerization inhibitors.
    Aguayo-Ortiz R, Cano-González L, Castillo R, Hernández-Campos A, Dominguez L.
    Chem Biol Drug Des; 2017 Jul 29; 90(1):40-51. PubMed ID: 28004475
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.